Kesimpta available through AllianceRx Walgreens Prime
ORLANDO, Fla. — Kesimpta (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing forms of multiple sclerosis (MS) in adults, is available through AllianceRx Walgreens Prime. MS is a rare disease of the central nervous system that affects nearly 1 million people in the United States, according to the National MS Society. MS disrupts the flow of information
